{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T10:44:45Z","timestamp":1785321885893,"version":"3.55.0"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T00:00:00Z","timestamp":1657584000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Boron neutron capture therapy (BNCT), a cellular-level particle radiation therapy, combines boron compounds selectively delivered to tumor tissue with neutron irradiation. Boronophenylalanine (BPA) is a boron compound widely used in malignant melanoma, malignant brain tumors, and recurrent head and neck cancer. However, neither basic nor clinical research was reported for the treatment of gastric cancer using BPA. Selective distribution of boron in tumors rather than that in blood or normal tissue prior to neutron irradiation is required for the successful treatment of BNCT. This study evaluated the pharmacokinetics and safety of <jats:sup>10<\/jats:sup>B-labeled BPA (<jats:sup>10<\/jats:sup>B-BPA, abbreviated as BPA) and its uptakes in gastric cancer. Pharmacokinetics and safety were evaluated in Sprague\u2013Dawley (SD) rats intravenously injected with BPA. The uptakes of boron in gastric cancer cell line MKN45 and in cell-derived xenografts (CDX) and patient-derived xenografts (PDX) animal models were measured. The results showed that the boron concentration in the blood of rats decreased fast in the first 30 min followed by a steady decrease following the observation time, having a half-life of 44.11 \u00b1 8.90 min and an AUC-last of 815.05 \u00b1 62.09 min\u00d7\u03bcg\/ml. The distribution of boron in different tissues (heart, liver, lung, stomach, and small intestine) of rats revealed a similar pattern in blood except for that in the brain, kidney, and bladder. In MKN45 cells, boron concentration increased in a time- and concentration-dependent manner. In both CDX and PDX animal models, the boron is preferentially distributed in tumor tissue rather than in blood or normal tissues. In addition, BPA had no significant adverse effects in rats. Taken together, the results suggested that BPA revealed a fast decrease in boron concentration in rats and is more likely to distribute in tumor cells and tissue.<\/jats:p>","DOI":"10.3389\/fonc.2022.925671","type":"journal-article","created":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T04:29:48Z","timestamp":1657600188000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Evaluation of Pharmacokinetics of Boronophenylalanine and Its Uptakes in Gastric Cancer"],"prefix":"10.3389","volume":"12","author":[{"given":"Futian","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shining","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianrong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjiao","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenxia","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohuan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucai","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11060-020-03586-6","article-title":"Boron Neutron Capture Therapy for Malignant Brain Tumors","volume":"149","author":"Miyatake","year":"2020","journal-title":"J Neurooncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1080\/0284186X.2021.1979646","article-title":"Accelerator-Based Boron Neutron Capture Therapy Facility at the Helsinki University Hospital","volume":"61","author":"Porra","year":"2022","journal-title":"Acta Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/jrr\/rrac012","article-title":"Profile Analysis of Adverse Events After Boron Neutron Capture Therapy for Head and Neck Cancer: A Sub-Analysis of the JHN002 Study","volume":"63","author":"Hirose","year":"2022","journal-title":"J Radiat Res"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.601820","article-title":"Boron Neutron Capture Therapy: A Review of Clinical Applications","volume":"11","author":"Malouff","year":"2021","journal-title":"Front Oncol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3390\/biology11010138","article-title":"In Vivo Accelerator-Based Boron Neutron Capture Therapy for Spontaneous Tumors in Large Animals: Case Series","volume":"11","author":"Kanygin","year":"2022","journal-title":"Biol (Basel)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.3390\/cells10112881","article-title":"Boron Neutron Capture Therapy (BNCT) for Cutaneous Malignant Melanoma Using (10)B-P-Boronophenylalanine (BPA) With Special Reference to the Radiobiological Basis and Clinical Results","volume":"10","author":"Fukuda","year":"2021","journal-title":"Cells"},{"key":"B7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13014-017-0949-y","article-title":"Dynamic Changes in (18)F-Borono-L-Phenylalanine Uptake in Unresectable, Advanced, or Recurrent Squamous Cell Carcinoma of the Head and Neck and Malignant Melanoma During Boron Neutron Capture Therapy Patient Selection","volume":"13","author":"Morita","year":"2018","journal-title":"Radiat Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.21147\/j.issn.1000-9604.2016.06.10","article-title":"Boron Neutron Capture Therapy for Malignant Melanoma: First Clinical Case Report in China","volume":"28","author":"Yong","year":"2016","journal-title":"Chin J Cancer Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"109105","DOI":"10.1016\/j.apradiso.2020.109105","article-title":"Using Salvage Boron Neutron Capture Therapy (BNCT) for Recurrent Malignant Brain Tumors in Taiwan","volume":"160","author":"Lan","year":"2020","journal-title":"Appl Radiat Isot"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2176\/nmc.ra.2015-0297","article-title":"Boron Neutron Capture Therapy for Malignant Brain Tumors","volume":"56","author":"Miyatake","year":"2016","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2020.11.001","article-title":"Boron Neutron Capture Therapy Using Cyclotron-Based Epithermal Neutron Source and Borofalan ((10)B) for Recurrent or Locally Advanced Head and Neck Cancer (JHN002): An Open-Label Phase II Trial","volume":"155","author":"Hirose","year":"2021","journal-title":"Radiother Oncol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"109212","DOI":"10.1016\/j.apradiso.2020.109212","article-title":"Boron Neutron Capture Therapy for Head and Neck Cancer: Relevance of Nuclear-Cytoplasmic Volume Ratio and Anti-Tumor Effect. -A Preliminary Report","volume":"163","author":"Aihara","year":"2020","journal-title":"Appl Radiat Isot"},{"key":"B13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.radonc.2009.01.010","article-title":"Impact of Accelerator-Based Boron Neutron Capture Therapy (AB-BNCT) on the Treatment of Multiple Liver Tumors and Malignant Pleural Mesothelioma","volume":"92","author":"Suzuki","year":"2009","journal-title":"Radiother Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2006.08.026","article-title":"Feasibility of Boron Neutron Capture Therapy (BNCT) for Malignant Pleural Mesothelioma From a Viewpoint of Dose Distribution Analysis","volume":"66","author":"Suzuki","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B15","doi-asserted-by":"publisher","first-page":"ZE01","DOI":"10.7860\/JCDR\/2016\/19890.9024","article-title":"Boron Neutron Capture Therapy - A Literature Review","volume":"10","author":"Nedunchezhian","year":"2016","journal-title":"J Clin Diagn Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.apradiso.2004.05.022","article-title":"Boron Biodistribution in Beagles After Intravenous Infusion of 4-Dihydroxyborylphenylalanine-Fructose Complex","volume":"61","author":"Kulvik","year":"2004","journal-title":"Appl Radiat Isot"},{"key":"B17","doi-asserted-by":"publisher","first-page":"109234","DOI":"10.1016\/j.apradiso.2020.109234","article-title":"Difference in BPA Uptake Between Glioma Stem-Like Cells and Their Cancerous Cells","volume":"164","author":"Yoshida","year":"2020","journal-title":"Appl Radiat Isot"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-019-00765-9","article-title":"Cellular Uptake Evaluation of Pentagamaboronon-0 (PGB-0) for Boron Neutron Capture Therapy (BNCT) Against Breast Cancer Cells","volume":"37","author":"Hermawan","year":"2019","journal-title":"Invest New Drugs"},{"key":"B19","article-title":"Evaluation of 4-Borono-2-18F-Fluoro-L-Phenylalanine-Fructose as a Probe for Boron Neutron Capture Therapy in a Glioma-Bearing Rat Model","volume":"45","author":"Wang","year":"2004","journal-title":"J Nucl Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-020-09925-3","article-title":"Gastric Cancer: A Comprehensive Review of Current and Future Treatment Strategies","volume":"39","author":"Sexton","year":"2020","journal-title":"Cancer Metastasis Rev"},{"key":"B21","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/00008390-199902000-00010","article-title":"Pharmacokinetics of 10B-P-Boronophenylalanine in Tumours, Skin and Blood of Melanoma Patients: A Study of Boron Neutron Capture Therapy for Malignant Melanoma","volume":"9","author":"Fukuda","year":"1999","journal-title":"Melanoma Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"109019","DOI":"10.1016\/j.apradiso.2019.109019","article-title":"Comparison of (18)FBPA Uptake With (18)FDG Uptake in Cancer Patients","volume":"157","author":"Igaki","year":"2020","journal-title":"Appl Radiat Isot"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1097\/00006123-200009000-00016","article-title":"Boron Neutron Capture Therapy of Brain Tumors: Biodistribution, Pharmacokinetics, and Radiation Dosimetry Sodium Borocaptate in Patients With Gliomas","volume":"47","author":"Goodman","year":"2000","journal-title":"Neurosurgery"},{"key":"B24","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40880-018-0295-y","article-title":"Clinical Trials for Treating Recurrent Head and Neck Cancer With Boron Neutron Capture Therapy Using the Tsing-Hua Open Pool Reactor","volume":"38","author":"Wang","year":"2018","journal-title":"Cancer Commun (Lond)"},{"key":"B25","doi-asserted-by":"publisher","first-page":"109308","DOI":"10.1016\/j.apradiso.2020.109308","article-title":"Pharmacokinetics of (10)B-P-Boronophenylalanine (BPA) in the Blood and Tumors in Human Patients: A Critical Review With Special Reference to Tumor-to-Blood (T\/B) Ratios Using Resected Tumor Samples","volume":"166","author":"Fukuda","year":"2020","journal-title":"Appl Radiat Isot"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-0122","article-title":"Evaluation of Alternative In Vivo Drug Screening Methodology: A Single Mouse Analysis","volume":"76","author":"Murphy","year":"2016","journal-title":"Cancer Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0b013e31827ab4c4","article-title":"Genetically Engineered Mouse Models of Pancreatic Cancer","volume":"18","author":"Westphalen","year":"2012","journal-title":"Cancer J"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201800617R","article-title":"Oncological and Genetic Factors Impacting PDX Model Construction With NSG Mice in Pancreatic Cancer","volume":"33","author":"Guo","year":"2019","journal-title":"FASEB J"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2010.05.001","article-title":"Efficacy of Anti-Cancer Agents in Cell Lines Versus Human Primary Tumour Tissue","volume":"10","author":"Cree","year":"2010","journal-title":"Curr Opin Pharmacol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2017.02.013","article-title":"Pancreatic Cancer Models for Translational Research","volume":"173","author":"Behrens","year":"2017","journal-title":"Pharmacol Ther"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.925671\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T04:29:51Z","timestamp":1657600191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.925671\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,12]]},"references-count":30,"alternative-id":["10.3389\/fonc.2022.925671"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.925671","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,12]]},"article-number":"925671"}}